Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 12/20 | 0.49 |
| ▸ | RXRG | P48443 | 10/20 | 0.49 |
| ▸ | RXRB | P28702 | 8/20 | 0.49 |
| ▸ | RARB | P10826 | 8/20 | 0.49 |
| ▸ | RARA | P10276 | 6/20 | 0.49 |
| ▸ | RARG | P13631 | 4/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6225322 | 1.00 | RXRA (0.49) | RXRARXRGRXRBRARBRARA | |
| SCHEMBL7030854 | 1.00 | RXRA (0.49) | RXRARXRGRXRBRARBRARA | |
| SCHEMBL6222353 | 0.90 | RXRA (0.54) | RXRARXRGRXRBRARBRARA | |
| SCHEMBL6222487 | 0.90 | RXRA (0.54) | RXRARXRGRXRBRARBRARA | |
| SCHEMBL6223471 | 0.89 | RXRA (0.63) | RXRARXRGRXRBRARBRARA | |
| SCHEMBL6225268 | 0.83 | RXRA (0.54) | RXRARXRGRXRBRARBRARA | |
| SCHEMBL6225273 | 0.83 | RXRA (0.54) | RXRARXRGRXRBRARBRARA | |
| SCHEMBL8334596 | 0.81 | RXRA (0.74) | RXRARXRGRXRBRARBRARA | |
| SCHEMBL21017664 | 0.81 | RXRA (0.74) | RXRARXRGRXRBRARBRARA | |
| SCHEMBL8340075 | 0.81 | RXRA (0.74) | RXRARXRGRXRBRARBRARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1117648-B1 | TETRAHYDROQUINOLINE DERIVATIVES HAVING SELECTIVE ACTIVITY FOR RETINOID X RECEPTORS | ALLERGAN INC (US) | 2003-08-06 | — | — | EP | claimed |
| EP-1117648-A1 | TETRAHYDROQUINOLINE DERIVATIVES HAVING SELECTIVE ACTIVITY FOR RETINOID X RECEPTORS | Allergan Sales, Inc. (US) | 2001-07-25 | — | — | EP | claimed |
| WO-2000020397-A1 | TETRAHYDROQUINOLINE DERIVATIVES HAVING SELECTIVE ACTIVITY FOR RETINOID X RECEPTORS | ALLERGAN SALES, INC. (US) | 2000-04-13 | — | — | WO | claimed |
| US-6048873-A | SKIN DISORDERS | ALLERGAN SALES, INC. (US) | 2000-04-11 | — | — | US | claimed |
| EP-1354878-B1 | Tetrahydroquinoline derivatives having selective activity for retinoid x receptors | ALLERGAN INC (US) | 2005-11-23 | — | — | EP | disclosed |
| EP-1354878-A2 | Tetrahydroquinoline derivatives having selective activity for retinoid x receptors | Allergan, Inc. (US) | 2003-10-22 | — | — | EP | disclosed |
| EP-1117648-B1 | TETRAHYDROQUINOLINE DERIVATIVES HAVING SELECTIVE ACTIVITY FOR RETINOID X RECEPTORS | ALLERGAN INC (US) | 2003-08-06 | — | — | EP | disclosed |
| EP-1117648-A1 | TETRAHYDROQUINOLINE DERIVATIVES HAVING SELECTIVE ACTIVITY FOR RETINOID X RECEPTORS | Allergan Sales, Inc. (US) | 2001-07-25 | — | — | EP | disclosed |
| WO-2000020397-A1 | TETRAHYDROQUINOLINE DERIVATIVES HAVING SELECTIVE ACTIVITY FOR RETINOID X RECEPTORS | ALLERGAN SALES, INC. (US) | 2000-04-13 | — | — | WO | disclosed |
| US-6048873-A | SKIN DISORDERS | ALLERGAN SALES, INC. (US) | 2000-04-11 | — | — | US | disclosed |